The U.S. Food and Drug Administration has limited the authorized use of the Janssen COVID-19 Vaccine to individuals 18 years of age and older for whom other authorized or approved COVID-19 vaccines are not accessible or clinically appropriate, and to individuals 18 years of age and older who elect to receive the Janssen COVID-19 Vaccine because they would otherwise not receive a COVID-19 vaccine.
FDA limits use of Janssen COVID-19 vaccine to certain individuals
May 8, 2022
![FDA limits use of Janssen COVID-19 vaccine to certain individuals](https://www.worldpharmanews.com/images/logo/fda.png)